Atlas Trials

A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance

Clinical trial NCT01953081 · COMPLETED

Trial details

NCT number
NCT01953081
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Enteral Feeding Intolerance
Start date
2014-01-01
Primary completion
2014-09-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.